prevention Archives -

Shares in PolyPid have been under pressure after the Israeli biotech reported its antibiotic for surgical site infections

Data dive could give PolyPid antibiotic a lifeline

https://pharmaphorum.com/news/data-dive-could-give-polypid-antibiotic-a-lifeline/

News/ News/ Sales and Marketing

Chasing rivals, AbbVie files migraine prevention drug atogepant in EU

Phil Taylor AbbVie, Biohaven Pharmaceuticals, CGRP, EU, migraine, Pfizer, prevention, Qulipta 0 Comment

AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the

Chasing rivals, AbbVie files migraine prevention drug atogepant in EU

https://pharmaphorum.com/news/chasing-rivals-abbvie-files-migraine-prevention-drug-atogepant-in-eu/

News/ News/ Sales and Marketing

AbbVie files Qulipta for chronic migraine prevention

Phil Taylor AbbVie, Biohaven Pharmaceuticals, migraine, Nurtec ODT, Pfizer, prevention, Qulipta 0 Comment

AbbVie has filed for approval of its oral CGRP inhibitor Qulipta for prevention of chronic migraine, seeking to

AbbVie files Qulipta for chronic migraine prevention

https://pharmaphorum.com/news/abbvie-files-qulipta-for-chronic-migraine-prevention/

News/ News/ R&D

AbbVie sees bigger role for Qulipta in migraine prevention

Phil Taylor AbbVie, Biohaven Pharmaceuticals, chronic migraine, migraine, prevention, Qulipta 0 Comment

AbbVie’s Qulipta has become the first oral drug in the CGRP inhibitor class to show efficacy in chronic

AbbVie sees bigger role for Qulipta in migraine prevention

https://pharmaphorum.com/news/abbvie-sees-bigger-role-for-qulipta-in-migraine-prevention/

News/ News/ Sales and Marketing

BMS’ Orencia gets FDA nod for GvHD thanks to real-world data

Phil Taylor Bristol-Myers Squibb, fda, graft versus host disease, Orencia, prevention, regulatory approval 0 Comment

Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia has been approved by the FDA to prevent graft versus host disease

BMS’ Orencia gets FDA nod for GvHD thanks to real-world data

https://pharmaphorum.com/news/bms-orencia-gets-fda-nod-for-gvhd-thanks-to-real-world-data/

Market Access/ News/ News

AZ files for emergency use of COVID-19 antibody combo in US

Phil Taylor antibody, AstraZeneca, AZD7442, coronavirus, COVID-19, prevention 0 Comment

AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent

AZ files for emergency use of COVID-19 antibody combo in US

https://pharmaphorum.com/news/az-files-for-emergency-use-of-covid-antibody-combo-in-us/

Market Access/ News/ News

AbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clash

Phil Taylor AbbVie, Biohaven Pharmaceuticals, CGRP, migraine, prevention, Qulipta 0 Comment

AbbVie has added a third drug to its arsenal in the crowded migraine market, getting FDA approval for

AbbVie’s Qulipta cleared for migraine prevention, setting up Biohaven clash

https://pharmaphorum.com/news/abbvies-qulipta-cleared-for-migraine-prevention-setting-up-biohaven-clash/

AstraZeneca plant. AstraZeneca has been working on a vaccine for the Coronavirus, COVID and COVID-19.

News/ News/ Patients

AZ’s COVID jab tackles delta variant, but antibody fails clinical trial

Phil Taylor antibody, AstraZeneca, coronavirus, COVID-19, COVID-19 vaccine, prevention, variant 0 Comment

The delta variant of COVID-19 may be holding back the lifting of lockdown restrictions in the UK, but

AZ’s COVID jab tackles delta variant, but antibody fails clinical trial

https://pharmaphorum.com/news/azs-covid-jab-tackles-delta-variant-but-antibody-fails-clinical-trial/

News/ News/ R&D/ Top stories

Novartis’ Aimovig tops topiramate in migraine face-off

Phil Taylor Aimovig, Amgen, CGRP, migraine, neurology, Novartis, prevention 0 Comment

Novartis’ injectable migraine prevention antibody Aimovig has been shown to be more effective than topiramate – a go-to

Novartis’ Aimovig tops topiramate in migraine face-off

https://pharmaphorum.com/news/novartis-aimovig-tops-topiramate-in-migraine-face-off/

Trending

prevention

Login